Using this method, researchers found that cancer‐related EGFR‐L858R (EGFR, epidermal growth factor receptor) and BRAF‐V600E mutations with allelic fractions as low as 0.1% can be detected in cell‐free DNA fragments. Here, EGFR is linked to cancer.